VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
TSX:VHI - Toronto Stock Exchange - CA92847V5018 - Common Stock - Currency: CAD
We assign a fundamental rating of 6 out of 10 to VHI. VHI was compared to 8 industry peers in the Health Care Technology industry. VHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make VHI suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
VHI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 1.79%, VHI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VHI has a better Return On Equity (2.71%) than 100.00% of its industry peers.
The Return On Invested Capital of VHI (3.20%) is better than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VHI is in line with the industry average of 3.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROIC | 3.2% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
VHI's Profit Margin of 5.99% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI has a Operating Margin of 12.27%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI's Operating Margin has improved in the last couple of years.
VHI has a better Gross Margin (80.89%) than 87.50% of its industry peers.
In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, VHI has more shares outstanding
The number of shares outstanding for VHI has been increased compared to 5 years ago.
Compared to 1 year ago, VHI has an improved debt to assets ratio.
2.2 Solvency
VHI has an Altman-Z score of 5.25. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
VHI has a better Altman-Z score (5.25) than 75.00% of its industry peers.
VHI has a debt to FCF ratio of 1.16. This is a very positive value and a sign of high solvency as it would only need 1.16 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.16, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that VHI is not too dependend on debt financing.
The Debt to Equity ratio of VHI (0.08) is better than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Altman-Z | 5.25 |
ROIC/WACC0.34
WACC9.4%
2.3 Liquidity
A Current Ratio of 1.59 indicates that VHI should not have too much problems paying its short term obligations.
VHI has a Current ratio of 1.59. This is in the better half of the industry: VHI outperforms 75.00% of its industry peers.
A Quick Ratio of 1.59 indicates that VHI should not have too much problems paying its short term obligations.
The Quick ratio of VHI (1.59) is better than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.00% over the past year.
Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 41.68%.
Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 46.32% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
3.2 Future
The Earnings Per Share is expected to grow by 82.32% on average over the next years. This is a very strong growth
VHI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.17% yearly.
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue Next Year46.71%
Revenue Next 2Y33.01%
Revenue Next 3Y22.17%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 127.70, which means the current valuation is very expensive for VHI.
Based on the Price/Earnings ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of VHI to the average of the S&P500 Index (26.85), we can say VHI is valued expensively.
With a Price/Forward Earnings ratio of 42.55, VHI can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 34.98. VHI is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 127.7 | ||
| Fwd PE | 42.55 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VHI is valued cheaper than 87.50% of the companies in the same industry.
87.50% of the companies in the same industry are more expensive than VHI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.97 | ||
| EV/EBITDA | 36.16 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VHI has a very decent profitability rating, which may justify a higher PE ratio.
VHI's earnings are expected to grow with 82.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.59
PEG (5Y)N/A
EPS Next 2Y107.06%
EPS Next 3Y82.32%
5. Dividend
5.1 Amount
No dividends for VHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (8/19/2025, 7:00:00 PM)
12.77
-0.13 (-1.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners34.31%
Inst Owner ChangeN/A
Ins Owners12.77%
Ins Owner ChangeN/A
Market Cap725.59M
Analysts81.54
Price Target14.99 (17.38%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.3%
Min EPS beat(2)-54.3%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-35.59%
Min EPS beat(4)-54.3%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-29.95%
EPS beat(12)1
Avg EPS beat(12)-44.36%
EPS beat(16)2
Avg EPS beat(16)-71.47%
Revenue beat(2)2
Avg Revenue beat(2)3.92%
Min Revenue beat(2)0.61%
Max Revenue beat(2)7.24%
Revenue beat(4)3
Avg Revenue beat(4)2.93%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)7.24%
Revenue beat(8)6
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)2.84%
Revenue beat(16)12
Avg Revenue beat(16)3.4%
PT rev (1m)5.8%
PT rev (3m)6.38%
EPS NQ rev (1m)-19.87%
EPS NQ rev (3m)-30.55%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)12.11%
Revenue NQ rev (3m)26.94%
Revenue NY rev (1m)12.3%
Revenue NY rev (3m)12.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 127.7 | ||
| Fwd PE | 42.55 | ||
| P/S | 8.78 | ||
| P/FCF | 53.97 | ||
| P/OCF | 51 | ||
| P/B | 3.98 | ||
| P/tB | 23.33 | ||
| EV/EBITDA | 36.16 |
EPS(TTM)0.1
EY0.78%
EPS(NY)0.3
Fwd EY2.35%
FCF(TTM)0.24
FCFY1.85%
OCF(TTM)0.25
OCFY1.96%
SpS1.45
BVpS3.21
TBVpS0.55
PEG (NY)0.59
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.79% | ||
| ROE | 2.71% | ||
| ROCE | 5.04% | ||
| ROIC | 3.2% | ||
| ROICexc | 5.66% | ||
| ROICexgc | N/A | ||
| OM | 12.27% | ||
| PM (TTM) | 5.99% | ||
| GM | 80.89% | ||
| FCFM | 16.27% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 1.16 | ||
| Debt/EBITDA | 0.87 | ||
| Cap/Depr | 10.65% | ||
| Cap/Sales | 0.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.38% | ||
| Profit Quality | 271.64% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.59 | ||
| Altman-Z | 5.25 |
F-Score3
WACC9.4%
ROIC/WACC0.34
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y215.37%
EPS Next 2Y107.06%
EPS Next 3Y82.32%
EPS Next 5YN/A
Revenue 1Y (TTM)41.68%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%46.93%
Revenue Next Year46.71%
Revenue Next 2Y33.01%
Revenue Next 3Y22.17%
Revenue Next 5YN/A
EBIT growth 1Y23.46%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year62.54%
EBIT Next 3Y48.37%
EBIT Next 5YN/A
FCF growth 1Y81.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.62%
OCF growth 3YN/A
OCF growth 5YN/A